MLKL and melanoma: Therefore, we assessed whether defects in MLKL-mediated necroptosis in tumor cells impacted DC functionality and the formation of ICI-enhanced antitumor T-cell responses, using our established model of MLKL−/− B16 melanoma-bearing mice (figure 3A).